Theravance Biopharma, Inc.

STATE OF WISCONSIN INVESTMENT BOARD TBPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

14,860

Value ($000)

278

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	278	0.0%	14,860	12/31/2025
2024 Q4	2/14/2025	546	0.0%	58,001	12/31/2024
2024 Q3	11/14/2024	921	0.0%	114,286	9/30/2024
2024 Q2	8/14/2024	1,098	0.0%	129,528	6/30/2024
2024 Q1	5/14/2024	1,074	0.0%	119,758	3/31/2024
2023 Q4	2/12/2024	510	0.0%	45,408	12/31/2023
2023 Q3	11/14/2023	405	0.0%	46,965	9/30/2023
2023 Q2	8/14/2023	501	0.0%	48,400	6/30/2023
2023 Q1	5/15/2023	551	0.0%	50,783	3/31/2023
2022 Q4	2/14/2023	645	0.0%	57,450	12/31/2022
2022 Q3	11/14/2022	573	0.0%	56,550	9/30/2022
2022 Q2	8/15/2022	537	0.0%	59,232	6/30/2022
2022 Q1	5/13/2022	627	0.0%	65,600	3/31/2022
2021 Q4	2/11/2022	725	0.0%	65,600	12/31/2021
2021 Q3	11/12/2021	485	0.0%	65,600	9/30/2021
2021 Q2	8/12/2021	953	0.0%	65,600	6/30/2021
2021 Q1	5/17/2021	1,339	0.0%	65,600	3/31/2021
2020 Q4	2/3/2021	1,166	0.0%	65,600	12/31/2020
2020 Q3	11/16/2020	1,091	0.0%	73,800	9/30/2020
2020 Q2	8/12/2020	1,549	0.0%	73,800	6/30/2020
2020 Q1	5/6/2020	1,752	0.0%	75,800	3/31/2020
2019 Q4	2/14/2020	1,717	0.0%	66,300	12/31/2019